We are live on ! Find out more
VNDA icon

Vanda Pharmaceuticals
VNDA

188 hedge funds and large institutions have $371M invested in Vanda Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 76 increasing their positions, 61 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,027% more call options, than puts

Call options by funds: $638K | Put options by funds: $30K

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

25% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 61

6% more funds holding

Funds holding: 177 → 188 (+11)

4.62% less ownership

Funds ownership: 102.55% → 97.93% (-4.6%)

6% less capital invested

Capital invested by funds: $396M → $371M (-$25M)

Holders
188
Holders Change
+11
Holders Change %
+6.21%
% of All Funds
2.95%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
76
Reduced
61
Closed
11
Calls
$638K
Puts
$30K
Net Calls
+$608K
Net Calls Change
+$624K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.56M
2
Goldman Sachs
Goldman Sachs
New York
+$2.9M
3
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$2.23M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$1.84M
5
Man Group
Man Group
United Kingdom
+$1.75M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$8.28M
2
Millennium Management
Millennium Management
New York
-$7.58M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$5.35M
4
EIP
Epoch Investment Partners
New York
-$4.8M
5
Allspring Global Investments
Allspring Global Investments
North Carolina
-$3.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
126
Amalgamated Bank
New York
$151K -$4.09K -638 -3%
EGM
127
Engineers Gate Manager
New York
$147K +$30.6K +4,777 +27%
LSV Asset Management
128
LSV Asset Management
Illinois
$146K -$328K -51,100 -70%
FRM
129
Fox Run Management
Connecticut
$144K +$140K +21,890 New
Envestnet Asset Management
130
Envestnet Asset Management
Illinois
$138K +$7.56K +1,180 +6%
OPERF
131
Oregon Public Employees Retirement Fund
Oregon
$118K -$5.13K -800 -4%
X
132
Xponance
Pennsylvania
$117K +$114K +17,819 New
TRSOTSOK
133
Teachers Retirement System of the State of Kentucky
Kentucky
$115K +$6.37K +993 +6%
ASRS
134
Arizona State Retirement System
Arizona
$105K -$2.87K -447 -3%
Teacher Retirement System of Texas
135
Teacher Retirement System of Texas
Texas
$102K -$13K -2,028 -12%
SOW
136
State of Wyoming
Wyoming
$87.5K +$54.6K +8,522 +179%
AC
137
AXQ Capital
New Jersey
$83.8K +$81.5K +12,713 New
ProShare Advisors
138
ProShare Advisors
Maryland
$82.8K +$3.49K +544 +5%
TI
139
Trexquant Investment
Connecticut
$80.2K -$239K -37,293 -75%
HighTower Advisors
140
HighTower Advisors
Illinois
$80K +$78.6K +12,263 New
EFM
141
E Fund Management
China
$78K -$7.87K -1,228 -9%
QT
142
Quantbot Technologies
New York
$77.8K +$34K +5,300 +82%
T. Rowe Price Associates
143
T. Rowe Price Associates
Maryland
$76K +$6.72K +1,049 +10%
New York State Common Retirement Fund
144
New York State Common Retirement Fund
New York
$74.7K -$393K -61,358 -84%
MOACM
145
Mutual of America Capital Management
New York
$73.9K -$3.03K -473 -4%
BCV
146
Banque Cantonale Vaudoise
Switzerland
$71K +$69.1K +10,783 New
Balyasny Asset Management
147
Balyasny Asset Management
Illinois
$67.8K +$66K +10,289 New
Lazard Asset Management
148
Lazard Asset Management
New York
$64K +$45.1K +7,041 +263%
Amundi
149
Amundi
France
$50.3K +$795 +124 +2%
Zurich Cantonal Bank
150
Zurich Cantonal Bank
Switzerland
$48.4K – – –
4 5
6
7 8

VNDA Hedge Fund Activity: Q2 2023 in Review

188 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Vanda Pharmaceuticals (VNDA) for Q2 2023, worth a combined $371M — down 6.3% from $396M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new VNDA positions and 11 closed out — a net gain of 11 holders — while 76 added to existing stakes and 61 trimmed.

The largest buyer was BlackRock, adding an estimated $4.56M. The largest seller was Bank of America, cutting an estimated $8.28M.

  • 188 institutional investors held Vanda Pharmaceuticals (VNDA) as of Q2 2023, up from 177 in Q1 2023.
  • Funds reported $371M of Vanda Pharmaceuticals stock for Q2 2023, down 6.3% quarter-over-quarter.
  • 22 funds opened new Vanda Pharmaceuticals positions in Q2 2023 and 11 closed out, a net change of +11 holders.
  • The largest Vanda Pharmaceuticals buyer in Q2 2023 was BlackRock, an estimated $4.56M added.
  • The largest Vanda Pharmaceuticals seller in Q2 2023 was Bank of America, an estimated $8.28M sold.

Based on aggregated 13F filings for Q2 2023.